{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-022919","form_type":"8-K","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2024-07-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.458181+00:00","generated_at":"2026-05-31T20:22:32.417303+00:00","sec_items":["1.01","2.03","7.01","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OPKO Health issues $250M senior secured notes due 2044, secured by NGENLA profit share payments from Pfizer","bullets":["Notes bear interest at 3-month SOFR + 7.5% (floor 4%); interest-only for first 4 years.","No principal payments required before July 2028; principal repaid from NGENLA profit share payments.","Proceeds provide non-dilutive capital for R&D, including multispecific antibody programs, and potential share/convertible note repurchases.","Exit fee of 3% on repayment; make-whole provision up to 200% of principal if prepaid after year 5.","OPKO retains full benefit of up to $100M in remaining milestone payments from Pfizer for NGENLA."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-022919","json":"https://secwatch.observer/filing/0001437749-24-022919.json","markdown":"https://secwatch.observer/filing/0001437749-24-022919.md","text":"https://secwatch.observer/filing/0001437749-24-022919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/0001437749-24-022919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000143774924022919/opk20240717_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T20:22:32.417303+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}